Cytokinesis-Block Micronucleus Assay Using Human Lymphocytes as a Sensitive Tool for Cytotoxicity/Genotoxicity Evaluation of AgNPs; ACS Omega; Vol. 5, iss. 21

التفاصيل البيبلوغرافية
Parent link:ACS Omega
Vol. 5, iss. 21.— 2020.— [P. 12005-12015]
مؤلف مشترك: Национальный исследовательский Томский политехнический университет Исследовательская школа химических и биомедицинских технологий
مؤلفون آخرون: Ruiz-Ruiz B. Balam, Arellano-Garcia M. E. Maria Evarista, Radilla-Chaves P. Patricia, Salas-Vargas D. S. David Sergio, Toledano-Magana Ya. Yanis, Casillas-Figueroa F. Francisco, Vazquez-Gomez R. L. Roberto, Pestryakov A. N. Aleksey Nikolaevich
الملخص:Title screen
Silver nanoparticles (AgNPs) are the most used nanomaterials worldwide due to their excellent antibacterial, antiviral, and antitumor activities, among others. However, there is scarce information regarding their genotoxic potential measured using human peripheral blood lymphocytes. In this work, we present the cytotoxic and genotoxic behavior of two commercially available poly(vinylpyrrolidone)-coated silver nanoparticle (PVP–AgNPs) formulations that can be identified as noncytotoxic and nongenotoxic by just evaluating micronuclei (MNi) induction and the mitotic index, but present enormous differences when other parameters such as cytostasis, apoptosis, necrosis, and nuclear damage (nuclear buds (NBUDs) and nucleoplasmic bridges (NPBs)) are analyzed. The results show that Argovit (35 nm PVP–AgNPs) and nanoComposix (50 nm PVP–AgNPs), at concentrations from 0.012 to 12 µg/mL, produce no changes in the nuclear division index (NDI) or micronuclei (MNi) frequency compared with the values found on control cultures of human blood peripheral lymphocytes from a healthy donor. Still, 50 nm PVP–AgNPs significantly decrease the replication index and significantly increase cytostasis, apoptosis, necrosis, and the frequencies of nuclear buds (NBUDs) and nucleoplasmic bridges (NPBs). These results provide evidence that the cytokinesis-block micronucleus (CBMN) assay using human lymphocytes and evaluating the eight parameters provided by the technique is a sensitive, fast, accurate, and inexpensive detection tool to support or discard AgNPs or other nanomaterials, which is worthwhile for continued testing of their effectiveness and toxicity for biomedical applications. In addition, it provides very important information about the role played by the [coating agent]/[metal] ratio in the design of nanomaterials that could reduce adverse effects as much as possible while retaining their therapeutic capabilities.
Режим доступа: по договору с организацией-держателем ресурса
اللغة:الإنجليزية
منشور في: 2020
الموضوعات:
الوصول للمادة أونلاين:https://doi.org/10.1021/acsomega.0c00149
التنسيق: الكتروني فصل الكتاب
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=662564

MARC

LEADER 00000naa0a2200000 4500
001 662564
005 20250407104740.0
035 |a (RuTPU)RU\TPU\network\33719 
035 |a RU\TPU\network\33704 
090 |a 662564 
100 |a 20200903d2020 k||y0rusy50 ba 
101 0 |a eng 
102 |a US 
135 |a drcn ---uucaa 
181 0 |a i  
182 0 |a b 
200 1 |a Cytokinesis-Block Micronucleus Assay Using Human Lymphocytes as a Sensitive Tool for Cytotoxicity/Genotoxicity Evaluation of AgNPs  |f B. Ruiz-Ruiz, M. E. Arellano-Garcia, P. Radilla-Chaves [et al.] 
203 |a Text  |c electronic 
300 |a Title screen 
330 |a Silver nanoparticles (AgNPs) are the most used nanomaterials worldwide due to their excellent antibacterial, antiviral, and antitumor activities, among others. However, there is scarce information regarding their genotoxic potential measured using human peripheral blood lymphocytes. In this work, we present the cytotoxic and genotoxic behavior of two commercially available poly(vinylpyrrolidone)-coated silver nanoparticle (PVP–AgNPs) formulations that can be identified as noncytotoxic and nongenotoxic by just evaluating micronuclei (MNi) induction and the mitotic index, but present enormous differences when other parameters such as cytostasis, apoptosis, necrosis, and nuclear damage (nuclear buds (NBUDs) and nucleoplasmic bridges (NPBs)) are analyzed. The results show that Argovit (35 nm PVP–AgNPs) and nanoComposix (50 nm PVP–AgNPs), at concentrations from 0.012 to 12 µg/mL, produce no changes in the nuclear division index (NDI) or micronuclei (MNi) frequency compared with the values found on control cultures of human blood peripheral lymphocytes from a healthy donor. Still, 50 nm PVP–AgNPs significantly decrease the replication index and significantly increase cytostasis, apoptosis, necrosis, and the frequencies of nuclear buds (NBUDs) and nucleoplasmic bridges (NPBs). These results provide evidence that the cytokinesis-block micronucleus (CBMN) assay using human lymphocytes and evaluating the eight parameters provided by the technique is a sensitive, fast, accurate, and inexpensive detection tool to support or discard AgNPs or other nanomaterials, which is worthwhile for continued testing of their effectiveness and toxicity for biomedical applications. In addition, it provides very important information about the role played by the [coating agent]/[metal] ratio in the design of nanomaterials that could reduce adverse effects as much as possible while retaining their therapeutic capabilities. 
333 |a Режим доступа: по договору с организацией-держателем ресурса 
461 |t ACS Omega 
463 |t Vol. 5, iss. 21  |v [P. 12005-12015]  |d 2020 
610 1 |a электронный ресурс 
610 1 |a труды учёных ТПУ 
610 1 |a лимфоциты 
610 1 |a цитотоксичность 
610 1 |a генотоксичность 
701 1 |a Ruiz-Ruiz  |b B.  |g Balam 
701 1 |a Arellano-Garcia  |b M. E.  |g Maria Evarista 
701 1 |a Radilla-Chaves  |b P.  |g Patricia 
701 1 |a Salas-Vargas  |b D. S.  |g David Sergio 
701 1 |a Toledano-Magana  |b Ya.  |g Yanis 
701 1 |a Casillas-Figueroa  |b F.  |g Francisco 
701 1 |a Vazquez-Gomez  |b R. L.  |g Roberto 
701 1 |a Pestryakov  |b A. N.  |c Chemist  |c Professor of Tomsk Polytechnic University, Doctor of Chemical Science  |f 1963-  |g Aleksey Nikolaevich  |3 (RuTPU)RU\TPU\pers\30471  |9 14796 
712 0 2 |a Национальный исследовательский Томский политехнический университет  |b Исследовательская школа химических и биомедицинских технологий  |c (2017- )  |3 (RuTPU)RU\TPU\col\23537  |9 28334 
801 2 |a RU  |b 63413507  |c 20200903  |g RCR 
856 4 |u https://doi.org/10.1021/acsomega.0c00149 
942 |c CF